These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 29396778)

  • 21. Dysmorphic features: an important clue to the diagnosis and severity of fetal anticonvulsant syndromes.
    Kini U; Adab N; Vinten J; Fryer A; Clayton-Smith J;
    Arch Dis Child Fetal Neonatal Ed; 2006 Mar; 91(2):F90-5. PubMed ID: 16239295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fetal Valproate Syndrome with Limb Defects: An Indian Case Report.
    Goyal M; Gupta A; Sharma M; Mathur P; Bansal N
    Case Rep Pediatr; 2016; 2016():3495910. PubMed ID: 28003925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Possible valproate teratogenicity.
    Tein I; MacGregor DL
    Arch Neurol; 1985 Mar; 42(3):291-3. PubMed ID: 3919693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dose dependence of fetal malformations associated with valproate.
    Vajda FJ; O'Brien TJ; Graham JE; Lander CM; Eadie MJ
    Neurology; 2013 Sep; 81(11):999-1003. PubMed ID: 23911758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Valproic acid silencing of ascl1b/Ascl1 results in the failure of serotonergic differentiation in a zebrafish model of fetal valproate syndrome.
    Jacob J; Ribes V; Moore S; Constable SC; Sasai N; Gerety SS; Martin DJ; Sergeant CP; Wilkinson DG; Briscoe J
    Dis Model Mech; 2014 Jan; 7(1):107-17. PubMed ID: 24135485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Valproate embryopathy: clinical and cognitive profile in 5 siblings.
    Schorry EK; Oppenheimer SG; Saal HM
    Am J Med Genet A; 2005 Mar; 133A(2):202-6. PubMed ID: 15669094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NRF2 activation protects against valproic acid-induced disruption of neurogenesis in P19 cells.
    Piorczynski TB; Larsen MW; Lee SJ; Hansen JM
    Differentiation; 2022; 123():18-29. PubMed ID: 34902770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Valproate treatment during pregnancy: description of four cases with foetal valproate syndrome].
    Sabers A; Larsen K; Blichfeldt S; Sahlholdt L; Rasmussen JO
    Ugeskr Laeger; 2009 Jan; 171(4):221-5. PubMed ID: 19174036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiepileptic drug combinations not involving valproate and the risk of fetal malformations.
    Vajda FJ; O'Brien TJ; Lander CM; Graham J; Eadie MJ
    Epilepsia; 2016 Jul; 57(7):1048-52. PubMed ID: 27265509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The fetal valproate syndrome.
    DiLiberti JH; Farndon PA; Dennis NR; Curry CJ
    Am J Med Genet; 1984 Nov; 19(3):473-81. PubMed ID: 6439041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A male with fetal valproate syndrome and autism.
    Williams PG; Hersh JH
    Dev Med Child Neurol; 1997 Sep; 39(9):632-4. PubMed ID: 9344057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes of pregnancies in women taking antiepileptic drugs for non-epilepsy indications.
    Jazayeri D; Graham J; Hitchcock A; O'Brien TJ; Vajda FJE
    Seizure; 2018 Mar; 56():111-114. PubMed ID: 29471258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intrauterine valproate exposure is associated with alterations in hippocampal cell numbers and folate metabolism in a rat model of valproate teratogenicity.
    Semmler A; Frisch C; Bleul C; Smith D; Bigler L; Prost JC; Blom H; Linnebank M
    Seizure; 2017 Mar; 46():7-12. PubMed ID: 28212902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exencephaly and axial skeletal malformations induced by maternal administration of sodium valproate in the MF1 mouse.
    Padmanabhan R; Hameed MS
    J Craniofac Genet Dev Biol; 1994; 14(3):192-205. PubMed ID: 7852547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fetal valproate syndrome and autism: additional evidence of an association.
    Williams G; King J; Cunningham M; Stephan M; Kerr B; Hersh JH
    Dev Med Child Neurol; 2001 Mar; 43(3):202-6. PubMed ID: 11263692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fetal valproate syndrome as a phenocopy of Kleefstra syndrome.
    Arora V; Joshi A; Lall M; Agarwal S; Bijarnia Mahay S; Dua Puri R; Chander Verma I
    Birth Defects Res; 2018 Sep; 110(15):1205-1209. PubMed ID: 30151876
    [No Abstract]   [Full Text] [Related]  

  • 37. 'Foetal valproate syndrome and autism: additional evidence of an association'.
    Bescoby-Chambers N; Forster P; Bates G
    Dev Med Child Neurol; 2001 Dec; 43(12):847. PubMed ID: 11769274
    [No Abstract]   [Full Text] [Related]  

  • 38. Associations between particular types of fetal malformation and antiepileptic drug exposure in utero.
    Vajda FJ; O'Brien TJ; Graham J; Lander CM; Eadie MJ
    Acta Neurol Scand; 2013 Oct; 128(4):228-34. PubMed ID: 23461556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fetal valproate phenotype is recognisable by mid pregnancy.
    Serville F; Carles D; Guibaud S; Dallay D
    J Med Genet; 1989 May; 26(5):348-9. PubMed ID: 2499680
    [No Abstract]   [Full Text] [Related]  

  • 40. Valproate teratogenicity and epilepsy syndrome.
    Bromfield EB; Dworetzky BA; Wyszynski DF; Smith CR; Baldwin EJ; Holmes LB
    Epilepsia; 2008 Dec; 49(12):2122-4. PubMed ID: 18557775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.